LONG BEACH, Calif.--(BUSINESS WIRE)--Obagi Medical Products, Inc. (NASDAQ: OMPI), a leader in topical aesthetic and therapeutic skin systems, with ongoing success in the physician-dispensed market, today announced that it has ceased selling SoluCLENZ Rx Gel™ which had been sold through pharmacies since August 2008.
